julie sweet breast cancer

Accenture CEO diagnosed with breast cancer

Accenture CEO Julie Sweet’s cancer diagnosis shows how execs should share life-altering health events

Diane Brady on how CEOs should handle a cancer diagnosis. The big story: Reciprocal trade tariffs. The markets: Approaching all-time highs, again. Analyst notes from JP Morgan, Goldman Sachs, Wedbush.

The Daily Beast on MSN · 17h

Accenture CEO’s Cancer Diagnosis Gives Insight Into How Execs Divulge Illness

Accenture CEO Julie Sweet was praised this week for her openness regarding a breast cancer diagnosis, which also gave rare insight into how executives disclose their life-altering health news. Sweet,

moneycontrol.com · 1d

Accenture CEO Julie Sweet diagnosed with early-stage breast cancer, treatment likely to last 12-16 weeks

Nonetheless, the CEO of the world’s largest IT company will lead its day-to-day operations throughout the process.

Investing.com on MSN · 2d

Accenture CEO Julie Sweet shares health update

Accenture plc (NYSE:ACN), a $243 billion market cap technology consulting giant, disclosed an update on the health of Julie Sweet, the company's Chair and Chief Executive Officer. In a message to all Accenture employees,

Meet CEO of one of world's biggest IT firms, who will undergo treatment for breast cancer

Julie Sweet, Chief Executive Officer of Accenture has recently been diagnosed with early-stage breast cancer and will undergo the treatment for about 12-16 weeks.

CRN5y

Accenture Names Julie Sweet CEO

Sweet has been CEO ... forward to working closely with Julie as chief executive officer.” Nanterme, who had been CEO since 2011, was diagnosed with colon cancer in July 2016 and underwent ...

Results that may be inaccessible to you are currently showing.

Hide inaccessible results

Accenture CEO diagnosed with breast cancer

Trending now